Probiotics to prevent gastrointestinal toxicity from cancer therapy: An interpretive review and call to action

Keyphrases

• Cancer Therapy 100%
• Gastrointestinal Toxicity 100%
• Call to Action 100%
• Clinical Trials 66%
• Human Trials 66%
• Rational Design 66%
• Probiotic Products 66%
• Chemotherapy 33%
• Abdominal Cancer 33%
• Radiation Therapy 33%
• Patient Demographics 33%
• Enteritis 33%
• Gastrointestinal Diseases 33%
• Gut Microbiota 33%
• Human Studies 33%
• Unmet Needs 33%
• Widespread Adoption 33%
• Mucositis 33%
• Pelvic Cancer 33%
• Modeling Data 33%
• Probiotic Administration 33%
• Probiotic Strains 33%
• Lactobacillus Probiotics 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Malignant Neoplasm 100%
• Gastrointestinal Toxicity 100%
• Chemotherapy 33%
• Gastrointestinal Symptom 33%
• Enteritis 33%
• Human Study 33%
• Intestine Flora 33%
• Lactobacillus 33%
• Mucosa Inflammation 33%
• Abdominal Cancer 33%
• Pelvis Cancer 33%